JPRN-UMIN000030957已完成未知
Validation of novel diagnostic marker of lung squamous cell carcinoma by using detection of urinary protein fragment: a multicenter study - Validation of diagnostic accuracy of urinary marker for lung squamous cell carcinoma
niversity of Miyazaki0 个研究点目标入组 190 人开始时间: 2018年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 190
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with lung squamous cell carcinoma 1.Patients who received treatment for lung squamous cell carcinoma 2. Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 3.Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 4.Patients who have current malignant neoplasm other than lung squamous cell carcinoma, or past history of malignant neoplasm within 5 years. 5.Patients who were diagnosed with other types of lung cancer (not lung squamous cell carcinoma) 6.Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 7.Patients who is pregnant or who is suspected to be pregnant. 8.Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 9.Patients whose attending physicians consider to be inappropriate for this study. Patients with COPD 1.Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 2.Patients who have current malignant neoplasm other than lung squamous cell carcinoma, or past history of malignant neoplasm within 5 years. 3.Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 4.Patients who is pregnant or who is suspected to be pregnant. 5.Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 6.Patients who were clinicaly suspected lung cancer by high resolution CT within 3 months. 7.Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 8.Patients whose attending physicians consider to be inappropriate for this study. Healthy controls 1-5. Same criterias as COPD (1-5.) 6.Those who are current smokers or ex-smokers. 7.Those whose attending physicians consider to be inappropriate for this study.
研究者
相似试验
已完成
不适用
Validation of novel diagnostic marker of lung adenocarcinoma by using detection of urinary protein fragment: a multicenter studyung adenocarcinomaJPRN-UMIN000030956niversity of Miyazaki190
进行中（未招募）
Unknown
Early detection of chronic obstructive pulmonary disease (COPD) using a novel technique for assessing lung unevenness (inhomogeneity)Chronic obstructive pulmonary diseaseRespiratoryISRCTN46851791niversity of Oxford180
进行中（未招募）
不适用
Determination and Validation of a Multi-analyte Assay for Lung Cancer ScreeningLung CancerNCT04968548Nucleix Ltd.5,000
尚未招募
不适用
se of lung ultrasound machine for early diagnosis of pneumonia caused in patients who are on mechanical ventilator in ICCTRI/2022/02/040182INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES
招募中
不适用
Lung EpiCheck Biomarkers Development StudyLung CancerNCT06245876Nucleix Ltd.6,000